Proprietary AI analyst is now available
- Public Comps
- Lir Life Sciences
Lir Life Sciences Valuation Multiples
Discover Lir Life Sciences' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Nyrstar, Coil, Bitros Holdings, Pipe Works L Girakian and more.
Lir Life Sciences Overview
About Lir Life Sciences
Lir Life Sciences Corp is a biotechnology company developing transdermal and sublingual drug-delivery technologies for GLP-1-based obesity therapies, with the focus of improving accessibility and patient experience.
Founded
N/A
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$8M
Valuation Multiples
Start free trialLir Life Sciences Financials
Lir Life Sciences reported last fiscal year revenue of - and negative EBITDA of ($298K).
In the same fiscal year, Lir Life Sciences generated ($298K) in EBITDA losses and had net loss of ($298K).
Lir Life Sciences P&L
In the most recent fiscal year, Lir Life Sciences reported revenue of - and EBITDA of ($298K).
Lir Life Sciences is unprofitable as of last fiscal year, with EBITDA margin of - and net margin of -.
Financial data powered by Morningstar, Inc.
Lir Life Sciences Stock Performance
Lir Life Sciences has current market cap of $8M, and enterprise value of $8M.
Market Cap Evolution
Lir Life Sciences' stock price is $0.30.
Lir Life Sciences share price decreased by 5.3% in the last 30 days.
Lir Life Sciences has an EPS (earnings per share) of $-0.01.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $8M | $8M | 13.3% | -5.3% | - | - | $-0.01 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLir Life Sciences Valuation Multiples
Lir Life Sciences trades at (27.7x) EV/EBITDA.
Lir Life Sciences Financial Valuation Multiples
As of June 26, 2026, Lir Life Sciences has market cap of $8M and EV of $8M.
Lir Life Sciences has a P/E ratio of (27.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lir Life Sciences Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lir Life Sciences Competitors
Lir Life Sciences competitors include Nyrstar, Coil, Bitros Holdings, Pipe Works L Girakian, Naughty Ventures, American Lithium Minerals, Afric Industries, Beowulf Mining, Nordic Flanges Group and Mangels.
Most Lir Life Sciences public comparables operate across Metals & Mining.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| - | - | (3.0x) | - | |||
| 0.5x | - | (8.0x) | - | |||
| - | - | - | - | |||
| - | - | - | - | |||
| - | - | (15.1x) | - | |||
| - | - | - | - | |||
| 2.2x | - | 9.0x | - | |||
| - | - | (2.8x) | - | |||
This data is available for Pro users. Sign up to see all Lir Life Sciences competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Lir Life Sciences
Lir Life Sciences has acquired 1 company to date.
Last acquisition by Lir Life Sciences was on November 10th 2025. Lir Life Sciences acquired LIR life Sciences for undisclosed valuation.
Latest Acquisitions by Lir Life Sciences
| Description | LIR Life Sciences is a biopharmaceutical company developing treatments for obesity and metabolic disorders while expanding into additional therapy areas with next-generation drug candidates. |
| HQ Country | |
| HQ City | Vancouver |
| Deal Date | 10 Nov 2025 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Lir Life Sciences acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lir Life Sciences
| Where is Lir Life Sciences headquartered? | Lir Life Sciences is headquartered in Canada. |
| Is Lir Life Sciences publicly listed? | Yes, Lir Life Sciences is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of Lir Life Sciences? | Lir Life Sciences trades under SKNY ticker. |
| When did Lir Life Sciences go public? | Lir Life Sciences went public in 2025. |
| Who are competitors of Lir Life Sciences? | Lir Life Sciences main competitors include Nyrstar, Coil, Bitros Holdings, Pipe Works L Girakian, Naughty Ventures, American Lithium Minerals, Afric Industries, Beowulf Mining, Nordic Flanges Group, Mangels. |
| What is the current market cap of Lir Life Sciences? | Lir Life Sciences' current market cap is $8M. |
| Is Lir Life Sciences profitable? | No, Lir Life Sciences is not profitable. |
| How many companies Lir Life Sciences has acquired to date? | As of June 2026, Lir Life Sciences has acquired 1 company. |
| What was the largest acquisition by Lir Life Sciences? | None of the M&A deals Lir Life Sciences has completed have disclosed valuations. |
| What companies Lir Life Sciences acquired? | Lir Life Sciences acquired LIR life Sciences. |
| In how many companies Lir Life Sciences has invested to date? | Lir Life Sciences hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Lir Life Sciences
Lists including Lir Life Sciences
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
